• FirefoxInstall the new Firefox »
  •  Dow Down 0.94% Nasdaq Down 1.00%

    More On UCBJF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    UCB S.A. (UCBJF)

    -Other OTC
    75.40 0.00(0.00%) Mar 24
    Add to Portfolio
    Prev Close:75.40
    Open:75.40
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:69.45 - 96.39
    Volume:0
    Avg Vol (3m):30
    Market Cap:N/A
    P/E (ttm):63.36
    EPS (ttm):1.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    UCB S.A., a biopharmaceutical company, focuses on various diseases in therapeutic areas of neurology and immunology in Belgium and internationally. The company’s products include Cimzia for Crohn’s disease, rheumatoid arthritis, psoriati... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback